Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 34.
Article
Amary, F;
Berisha, F;
Ye, H;
Gupta, M;
Gutteridge, A;
Baumhoer, D;
Gibbons, R;
... Flanagan, AM; + view all
(2017)
H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone.
American Journal of Surgical Pathology
, 41
(8)
pp. 1059-1068.
10.1097/PAS.0000000000000859.
|
|
Amary, F;
Markert, E;
Berisha, F;
Ye, H;
Gerrand, C;
Cool, P;
Tirabosco, R;
... Flanagan, AM; + view all
(2019)
FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool.
American Journal of Surgical Pathology
, 43
(12)
pp. 1661-1667.
10.1097/PAS.0000000000001355.
|
|
Amary, F;
Perez-Casanova, L;
Ye, H;
Cottone, L;
Strobl, A-C;
Cool, P;
Miranda, E;
... Flanagan, AM; + view all
(2019)
Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.
Modern Pathology
, 32
pp. 1762-1771.
10.1038/s41379-019-0315-8.
|
|
Amary, MF;
Ye, H;
Forbes, G;
Damato, S;
Maggiani, F;
Pollock, R;
Tirabosco, R;
(2015)
Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas.
Virchows Arch
, 466
(2)
217 - 222.
10.1007/s00428-014-1685-4.
|
 |
|
Balogh, P;
O'Donnell, P;
Lindsay, D;
Amary, MF;
Flanagan, AM;
Tirabosco, R;
(2020)
Extra‐axial Skeletal Poorly Differentiated Chordoma. A Case Report.
Histopathology
, 76
(6)
pp. 924-927.
10.1111/his.14056.
|
|
Behjati, S;
Gundem, G;
Wedge, DC;
Roberts, ND;
Tarpey, PS;
Cooke, SL;
Van Loo, P;
... Campbell, PJ; + view all
(2016)
Mutational signatures of ionizing radiation in second malignancies.
Nature Communications
, 7
, Article 12605. 10.1038/ncomms12605.
|
|
Behjati, S;
Tarpey, PS;
Sheldon, H;
Martincorena, I;
Van Loo, P;
Gundem, G;
Wedge, DC;
... Campbell, PJ; + view all
(2014)
Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
Nature Genetics
, 46
(4)
376 - 379.
10.1038/ng.2921.
|
|
Bekers, EM;
Groenen, PJTA;
Verdijk, MAJ;
Raaijmakers-van Geloof, WL;
Roepman, P;
Vink, R;
Gilhuijs, NDB;
... Flucke, U; + view all
(2017)
Soft tissue angiofibroma: Clinicopathologic, immunohistochemical and molecular analysis of 14 cases.
Genes Chromosomes & Cancer
, 56
(10)
pp. 750-757.
10.1002/gcc.22478.
|
 |
|
Cottone, L;
Eden, N;
Usher, I;
Lombard, P;
Ye, H;
Ligammari, L;
Lindsay, D;
... Flanagan, AM; + view all
(2020)
Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma.
Journal Of Pathology Clinical Research
, 6
(2)
pp. 113-123.
10.1002/cjp2.156.
|
|
|
De Noon, S;
Flanagan, AM;
Tirabosco, R;
O'Donnell, P;
Amary, F;
(2021)
EWSR1-SMAD₃ fibroblastic tumour of bone: expanding the clinical spectrum.
Skeletal Radiology
, 50
pp. 445-450.
10.1007/s00256-020-03563-0.
|
|
Feber, A;
Guilhamon, P;
Lechner, M;
Fenton, T;
Wilson, GA;
Thirlwell, C;
Morris, TJ;
... Beck, S; + view all
(2014)
Using high-density DNA methylation arrays to profile copy number alterations.
Genome Biol
, 15
(2)
, Article R30. 10.1186/gb-2014-15-2-r30.
|
|
|
Fernanda Amary, M;
Ye, H;
Berisha, F;
Khatri, B;
Forbes, G;
Lehovsky, K;
Frezza, AM;
... Flanagan, AM; + view all
(2014)
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy.
Cancer Med
, 3
(4)
pp. 980-987.
10.1002/cam4.268.
|
|
|
Fittall, MW;
Lyskjær, I;
Ellery, P;
Lombard, P;
Ijaz, J;
Strobl, A-C;
Oukrif, D;
... Flanagan, AM; + view all
(2020)
Drivers underpinning the malignant transformation of giant cell tumour of bone.
The Journal of Pathology
10.1002/path.5537.
(In press).
|
|
|
Flanagan, AM;
Lindsay, D;
(2017)
A diagnostic approach to bone tumours.
Pathology
, 49
(7)
pp. 675-687.
10.1016/j.pathol.2017.08.003.
|
|
Flanagan, AM;
Speight, PM;
(2014)
Giant cell lesions of the craniofacial bones.
Head Neck Pathol
, 8
(4)
445 - 453.
10.1007/s12105-014-0589-6.
|
|
|
Guilhamon, P;
Butcher, LM;
Presneau, N;
Wilson, GA;
Feber, A;
Paul, DS;
Schütte, M;
... Beck, S; + view all
(2014)
Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics.
Genome Med
, 6
(12)
, Article 116. 10.1186/s13073-014-0116-0.
|
|
|
Guilhamon, P;
Eskandarpour, M;
Halai, D;
Wilson, GA;
Feber, A;
Teschendorff, AE;
Gomez, V;
... Beck, S; + view all
(2013)
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2.
Nature Communications
, 4
, Article 2166. 10.1038/ncomms3166.
|
|
|
Gutteridge, A;
Rathbone, VM;
Gibbons, R;
Bi, M;
Archard, N;
J Davies, KE;
Brown, J;
... Forshew, T; + view all
(2017)
Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection.
Cancer Medicine
, 6
(10)
pp. 2194-2202.
10.1002/cam4.1146.
|
|
|
Henderson, SR;
Guiliano, D;
Presneau, N;
McLean, S;
Frow, R;
Vujovic, S;
Anderson, J;
... Boshoff, C; + view all
(2005)
A molecular map of mesenchymal tumors.
GENOME BIOL
, 6
(9)
, Article R76. 10.1186/gb-2005-6-9-r76.
|
|
|
Kalimuthu, SN;
Tilley, C;
Forbes, G;
Ye, H;
Lehovsky, K;
Pillay, N;
Seddon, BM;
... Flanagan, AM; + view all
(2015)
Clinical outcome in patients with peripherally-sited atypical lipomatous tumours and dedifferentiated liposarcoma.
The Journal of Pathology: Clinical Research
, 1
(2)
pp. 106-112.
10.1002/cjp2.12.
|
|
|
Lyskjær, I;
Lindsay, D;
Tirabosco, R;
Steele, CD;
Lombard, P;
Strobl, A-C;
Rocha, AM;
... Flanagan, AM; + view all
(2020)
H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours.
The Journal of Pathology
, 252
(2)
pp. 151-164.
10.1002/path.5507.
|
|
|
McConnell, L;
Houghton, O;
Stewart, P;
Gazdova, J;
Srivastava, S;
Kim, C;
Catherwood, M;
... Gonzalez, D; + view all
(2020)
A novel next generation sequencing approach to improve sarcoma diagnosis.
Modern Pathology
, 33
pp. 1350-1359.
10.1038/s41379-020-0488-1.
|
|
Mendoza-Naranjo, A;
El-Naggar, A;
Wai, DH;
Mistry, P;
Lazic, N;
Ayala, FR;
da Cunha, IW;
... Sorensen, PH; + view all
(2013)
ERBB4 confers metastatic capacity in Ewing sarcoma.
EMBO Mol Med
, 5
(7)
1019 - 1034.
10.1002/emmm.201202343.
|
|
|
Mirabello, L;
Zhu, B;
Koster, R;
Karlins, E;
Dean, M;
Yeager, M;
Gianferante, M;
... Savage, SA; + view all
(2020)
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
JAMA Oncology
10.1001/jamaoncol.2020.0197.
(In press).
|
|
Prendergast, SC;
Strobl, A-C;
Cross, W;
Pillay, N;
Strauss, SJ;
Ye, H;
Lindsay, D;
... Amary, F; + view all
(2020)
Sarcoma and the 100,000 Genomes Project: our experience and changes to practice.
The Journal of Pathology: Clinical Research
10.1002/cjp2.174.
(In press).
|
|
|
Presneau, N;
Duhamel, LA;
Ye, H;
Tirabosco, R;
Flanagan, AM;
Eskandarpour, M;
(2017)
Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcomas.
British Journal of Cancer
, 117
pp. 398-408.
10.1038/bjc.2017.174.
|
|
Puls, F;
Pillay, N;
Fagman, H;
Palin-Masreliez, A;
Amary, F;
Hansson, M;
Kindblom, L-G;
... Mertens, F; + view all
(2019)
PRDM10-rearranged Soft Tissue Tumor A Clinicopathologic Study of 9 Cases.
The American Journal of Surgical Pathology
, 43
(4)
pp. 504-513.
10.1097/PAS.0000000000001207.
|
|
Ribeiro, S;
Napoli, I;
White, IJ;
Parrinello, S;
Flanagan, AM;
Suter, U;
Parada, LF;
(2013)
Injury Signals Cooperate with Nf1 Loss to Relieve the Tumor-Suppressive Environment of Adult Peripheral Nerve.
Cell Rep
, 5
(1)
pp. 126-136.
10.1016/j.celrep.2013.08.033.
|
|
|
Scheipl, S;
Barnard, M;
Cottone, L;
Jorgensen, M;
Drewry, DH;
Zuercher, WJ;
Turlais, F;
... Flanagan, AM; + view all
(2016)
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
J Pathol
, 239
(3)
pp. 320-334.
10.1002/path.4729.
|
|
|
Schuh, A;
Dreau, H;
Knight, SJL;
Ridout, K;
Mizani, T;
Vavoulis, D;
Colling, R;
... Taylor, JC; + view all
(2018)
Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing.
Cold Spring Harbor Molecular Case Studies
, 4
(2)
, Article a002279. 10.1101/mcs.a002279.
|
|
|
Sieben, NLG;
Oosting, J;
Flanagan, AM;
Prat, J;
Roemen, GMJM;
Kolkman-Uljee, SM;
van Eijk, R;
... van Engeland, M; + view all
(2005)
Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors.
Journal of Clinical Oncology
, 23
(29)
7257 - 7264.
10.1200/JCO.2005.02.2541.
|
|
Tarpey, PS;
Behjati, S;
Young, MD;
Martincorena, I;
Alexandrov, LB;
Farndon, SJ;
Guzzo, C;
... Campbell, PJ; + view all
(2017)
The driver landscape of sporadic chordoma.
Nature Communications
, 8
, Article 890. 10.1038/s41467-017-01026-0.
|
|
|
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium;
(2020)
Pan-cancer analysis of whole genomes.
Nature
, 578
(7793)
pp. 82-93.
10.1038/s41586-020-1969-6.
|
|
|
Whelan, JS;
Bielack, SS;
Marina, N;
Smeland, S;
Jovic, G;
Hook, JM;
Krailo, M;
... on behalf of the EURAMOS collaborators; + view all
(2014)
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
Annals of Oncology
10.1093/annonc/mdu526.
|
|
